Acta Medica Scandinavica · 1982 · 39 citations · 24 references
MedicineEndocrinologyPharmacologyClinical PharmacologyDiabetologyMetabolic RegulationDiabetes ControlDiabetes ManagementDiabetes MellitusDiabetes PharmacotherapyGlycemic ControlBlood Glucose RegulationGlucose ConcentrationImpaired Glucose ToleranceImpaired Insulin SensitivityInsulin Sensitivity IndicesNonselective Beta BlockersNonselective Beta-blocker TherapyPropranolol Therapy
Two beta-blocking agents, non-selective propranolol and beta1-selective metoprolol, were investigated with respect to their effects on glucose metabolism in 10 hypertensive patients with non-insulin dependent diabetes mellitus (NIDDM). The patients were treated randomly for two weeks in double-blind cross-over manner with (a) propranolol, (b) metoprolol, and (c) placebo. Propranolol impaired glucose tolerance when compared to placebo. The increase in blood glucose was associated neither with changes in concentrations of serum insulin, plasma glucagon of free fatty acid nor with alterations in peripheral insulin sensitivity as measured by 125I-insulin binding to mononuclear leukocytes. Although metoprolol had no effect on blood glucose, it increased 125I-insulin binding to mononuclear leukocytes. The increase in insulin binding could contribute to blood glucose control during metoprolol treatment. In search for reasons for poor metabolic control in NIDDM, treatment with non-selective beta-blockers should be kept in mind.
24
Coated Charcoal Immunoassay of Insulin
Victor Herbert, Kam‐Seng Lau, Chester W. Gottlieb et al. · The Journal of Clinical Endocrinology & Metabolism · 1965 · 3K citations
Insulin Receptors in Human Circulating Cells and Fibroblasts
James R. Gavin, Jesse Roth, Phyllis Jen et al. · Proceedings of the National Academy of Sciences · 1972 · 226 citations
Alan D. Cherrington, F. Assimacopoulos, Sandra C. Harper et al. · Journal of Biological Chemistry · 1976 · 206 citations · Full text